Company Filing History:
Years Active: 1992
Title: Frank-Joachim Morich: Innovator in Monoclonal Antibodies
Introduction
Frank-Joachim Morich is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for medical diagnostics and therapeutic applications.
Latest Patents
Morich holds a patent for "Monoclonal antibodies against atrial natriuretic peptides of humans." This patent involves the production of monoclonal antibodies through deposited hybridoma cell lines 85031401 and 85031402, which are stored with the European Collection of Animal Cell Cultures. The hybridoma cells are created by fusing cells from mammals that produce antibodies against atrial natriuretic peptides. These antibodies can be utilized in assays to determine the levels of atrial natriuretic peptides in various biological samples, including blood, plasma, serum, urine, lymph, or cerebrospinal fluid. He has 1 patent to his name.
Career Highlights
Morich is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His role at Bayer has allowed him to work on innovative projects that advance medical science and improve patient care.
Collaborations
Throughout his career, Morich has collaborated with esteemed colleagues, including Claudia Hirth and Dieter Neuser. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Frank-Joachim Morich is a distinguished inventor whose work in monoclonal antibodies has the potential to impact medical diagnostics significantly. His contributions to biotechnology exemplify the importance of innovation in healthcare.